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The nonsense-mediated mRNA decay
SMG-1 kinase is regulated by large-scale
conformational changes controlled
by SMG-8
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University, School of Medicine, Fuku-ura, Kanazawa-ku, Yokohama 236-0004, Japan; 4Precursory Research for Embryonic
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Nonsense-mediated mRNA decay (NMD) is a eukaryotic surveillance pathway that regulates the degradation
of mRNAs harboring premature translation termination codons. NMD also influences the expression of many
physiological transcripts. SMG-1 is a large kinase essential to NMD that phosphorylates Upf1, which seems to be
the definitive signal triggering mRNA decay. However, the regulation of the kinase activity of SMG-1 remains
poorly understood. Here, we reveal the three-dimensional architecture of SMG-1 in complex with SMG-8 and
SMG-9, and the structural mechanisms regulating SMG-1 kinase. A bent arm comprising a long region of HEAT
(huntington, elongation factor 3, a subunit of PP2A and TOR1) repeats at the N terminus of SMG-1 functions as
a scaffold for SMG-8 and SMG-9, and projects from the C-terminal core containing the phosphatidylinositol
3-kinase domain. SMG-9 seems to control the activity of SMG-1 indirectly through the recruitment of SMG-8 to
the N-terminal HEAT repeat region of SMG-1. Notably, SMG-8 binding to the SMG-1:SMG-9 complex specifically
down-regulates the kinase activity of SMG-1 on Upf1 without contacting the catalytic domain. Assembly of the
SMG-1:SMG-8:SMG-9 complex induces a significant motion of the HEAT repeats that is signaled to the kinase
domain. Thus, large-scale conformational changes induced by SMG-8 after SMG-9-mediated recruitment tune
SMG-1 kinase activity to modulate NMD.
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Eukaryotic gene expression is exquisitely regulated at
several steps from gene transcription to the final synthe-
sis of proteins to ensure fidelity in the conversion of
genetic information into biological functions. A post-
transcriptional surveillance pathway known as nonsense-
mediated mRNA decay (NMD) is responsible for the
recognition and degradation of mRNAs containing pre-
mature translation termination codons (PTCs). The main
function of this pathway is to ensure thatmutatedmRNAs
harboring a PTC, which could generate potentially harm-
ful truncated proteins, are removed before translation
(Isken and Maquat 2008; Shyu et al. 2008). NMD also
regulates the abundance of many physiological mRNAs
contributing to the regulation of global gen expression
(Mendell et al. 2004; Stalder and Muhlemann 2008).
Seven conserved core proteins have been identified in
most metazoans as required for NMD. These are SMG-1,
Upf1, Upf2, Upf3, SMG-5, SMG-6, and SMG-7 (Yamashita
et al. 2005; Isken and Maquat 2008), a list that has been
enlarged recently by novel components of the NMD ma-
chinery; namely, SMG-8, SMG-9, Ruvbl1, Ruvbl2, RPB5,
and SMG-10 (Yamashita et al. 2009; Izumi et al. 2010).
Recent advances in the field have provided significant in-
sights into themechanisms ofNMD, but our understanding
is still incomplete (Rebbapragada and Lykke-Andersen
2009; Hwang et al. 2010; Nicholson et al. 2010). SMG-1 is
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one of the essential players triggering an NMD response,
since it is the kinase that phosphorylates the Upf1 pro-
tein. Upf1 phosphorylation is believed to be the definitive
signal triggering NMD.
SMG-1 is a very large protein (;410 kDa) belonging to
the phosphatidylinositol 3-kinase-related protein kinase
(PIKK) family of serine–threonine kinases (Abraham 2004;
Yamashita et al. 2005). In humans, the PIKK family com-
prises six members: ATM, ATR, DNA-PKcs, mTOR,
TRRAP, and SMG-1 (Abraham 2004; Lempiainen and
Halazonetis 2009). The primary structure of all PIKKs
contains a conserved C terminus preceded by a long
stretch of helical, mostly HEAT (huntington, elongation
factor 3, a subunit of PP2A and TOR1), repeats (Fig. 1A;
Lempiainen and Halazonetis 2009). HEAT repeats are
units of two anti-parallel a helices connected by flexible
loops, and many of these units organize large, superheli-
cal, frequently twisted structures that in many proteins
function as a scaffold for protein–protein interactions
(Bono et al. 2010). The required amino acid composition
and length of the helices and loops connecting these
helices in HEAT repeats are very flexible, allowing for
significant sequence divergence within the PIKK family
while maintaining the structural characteristics common
to all HEAT repeats (Perry and Kleckner 2003). The
extension of these HEAT regions, always N-terminal to
the conserved C-terminal domains, varies among these
kinases, and is significantly shorter in SMG-1 compared
with DNA-PKcs, one of the larger PIKKs (Fig. 1A). These
HEAT repeats are followed by a conserved C terminus,
comprising an ;600-amino-acid FAT (FRAP/TOR, ATM,
and TRRAP) domain, also thought to be assembled from
multiple helical repeats; the catalytic kinase domainwith
homology with the PI3K (;370 residues); and a short
(;70-residue) C-terminal FATC (FAT C-terminal) do-
main. The FATC is a short, highly conserved a-helical
domain that is critical for kinase activity and has been
suggested to be important in protein–protein interactions
(Lempiainen andHalazonetis 2009). Detailed information
about sequence conservation has been reviewed else-
where (Lempiainen and Halazonetis 2009). SMG-1 shares
these structural features common to all PIKKs, but a
unique >1000-amino-acid insertion of poorly character-
ized function is located between the kinase domain and
the FATC (Fig. 1A). A C-terminal fragment of SMG-1
encompassing the catalytic domain, the FATC, and the
insertion between these two domains has been implicated
in Upf2 recognition (Kashima et al. 2006). For simplicity, in
Figure 1. Purification of SMG-1, SMG-1:SMG-9, and SMG1C. (A) SMG-1 primary structure and comparison with DNA-PKcs. In this
study, the terms N-terminal and C-terminal are used to refer to the helical region and the conserved C-terminal domains, respectively.
(B) Western blots of HeLa TetOff cell lysates immunodepleted with anti-SMG-1, anti-SMG-8, or anti-SMG-9 antibody, or NRIgG
(normal rabbit immunoglobulin G). Immunodepleted lysates were analyzed using the antibodies indicated. Dilutions corresponding to
50%, 25%, 12.5%, or 6.25 of the NRIgG-depleted protein amount from the NRIgG-depleted lysate were loaded to assess the efficiency
of the immunodepletion. (C–E) SDS gel after silver staining of the fractions eluted from the affinity column for the purification of the
SMG1C complex (SMG-1:SMG-8:SMG-9) (C), the SMG-1:SMG-9 complex (D), or SMG-1 (E), all expressed in 293T cells.
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this study we use the terms N-terminal and C-terminal
domains of SMG-1 when referring to the HEAT repeat
region and the conserved C terminus (FAT, kinase, in-
sertion, and FATC domains), respectively (Fig. 1A).
The structural analysis of the PIKK kinases has been
found to be extremely challenging due to their large size,
their interaction with multiple partners, and the diffi-
culty of their purification. One of the best structurally
characterized members of the PIKK family is DNA-PKcs.
The three-dimensional (3D) structure of DNA-PKcs and
that of its complexes with DNA and Ku70/Ku80 have
been studied by 3D electron microscopy (3D-EM) (Rivera-
Calzada et al. 2005; Spagnolo et al. 2006; Williams et al.
2008) and SAXS (Hammel et al. 2010). These structures
defined two main structural regions in the protein: the
‘‘head’’ (bulky and containing the kinase domain), and
several arms containing regions of HEAT repeats. Re-
cently, a model based on crystallographic data at 6.6 A˚
resolution was proposed that unambiguously confirmed
the location of the kinase domain at the top of the head
region and suggested that the head possibly comprised
most of the conserved C-terminal domains (Sibanda et al.
2010). Interestingly, two arms of HEAT repeats project
from the head, forming an open ring that might partici-
pate in DNA binding (Supplemental Fig. S1; Rivera-
Calzada et al. 2005; Sibanda et al. 2010).
Two novel components of the NMD machinery have
been described recently as forming a complexwith SMG-1.
These two proteins, SMG-8 (991 amino acids) and SMG-9
(520 amino acids), appear to be tightly bound to SMG-1 to
form the so-called SMG1C complex (Yamashita et al. 2009).
We recently described that SMG-9 comprises a C-terminal
putative nucleotide-triphosphatase domain preceded by an
intrinsically disordered N-terminal region (Yamashita et al.
2009; Fernandez et al. 2010). Both domains are required to
interact with SMG-1, whereas the C terminus of SMG-9
interacts with SMG-8, showing also that SMG-8 and
SMG-9 can form a complex in the absence of SMG-1
(Fernandez et al. 2010). The association between SMG-8
and SMG-9with SMG-1 appears to be an absolute require-
ment for the regulation of the NMD response (Yamashita
et al. 2009). Here, we provide the molecular architecture
of the SMG1C complex using 3D-EM and the structural
basis for the regulation of SMG-1 by SMG-8 and SMG-9.
Results
SMG-9 plays a central role in the assembly of several
complexes in vivo
We performed a series of depletion experiments fromHeLa
TetOff cell extracts to reveal the complexes formed among
endogenous SMG-1, SMG-8, and SMG-9 in vivo. The ex-
tracts were depleted of either protein by specific anti-
bodies, and the remaining material was tested for the
presence of SMG-1, SMG-8, and SMG-9 by Western
blotting (Supplemental Fig. S2; Yamashita et al. 2009).
Under the conditions tested, a significant reduction of the
specific target protein was observed (Fig. 1B), but, inter-
estingly, although SMG1C seemed to be an abundant
complex, other subcomplexes were detected in vivo. When
SMG-1 was immunodepleted, the remaining extract re-
vealed significant amounts of SMG-8 and SMG-9 thatwere
not bound to SMG-1. Depletion of SMG-8 revealed the
existence of significant amounts of SMG-1 and SMG-9
molecules that were not bound to SMG-8, consistent with
the formation of complexes between SMG-1 and only
SMG-9, as later confirmed (see below). In addition, SMG-9
depletion removed most SMG-1 and a large proportion of
SMG-8, suggesting that the majority of SMG-1 and SMG-8
are bound to SMG-9. In this experiment, nondepleted
SMG-8 would correspond to free SMG-8 and/or putative
SMG-1:SMG-8 complexes, but the small amount of SMG-1
remaining after SMG-9 depletion indicated that SMG-1
does not significantly interact with SMG-8 independently
of SMG-9. Overall, these data revealed that SMG-1, SMG-8,
and SMG-9 assemble several complexes in vivo besides
SMG1C. Importantly, SMG-9 seems to play a major role
in the assembly of these complexes, and SMG-1 was not
detected bound to SMG-8 in the absence of SMG-9 in a
significant proportion (Fig. 1B; Yamashita et al. 2009).
This finding is consistent with the ability of SMG-8 and
SMG-9 to interact in the absence of SMG-1 described
previously (Fernandez et al. 2010).
These findings led us to purify SMG-1 as well as the
SMG-1:SMG-9 and SMG-1:SMG-8:SMG-9 complexes af-
ter transfection of human 293T cells with tagged versions
of the proteins (Fig. 1C,E). An extraordinary effort was
required to solve all of the challenges encountered during
the expression and purification of these complexes, and
key to our success was the combination of siRNA, an-
tibody depletion, and imaging in the electron microscope
during purification. The SMG1C complex was purified
from cells expressing SBP-SMG-1, HA-SMG-8, and HA-
SMG-9 using the SBP tag (Fig. 1C). SMG-1 copurified with
a significant amount of SMG-8 and SMG-9, suggesting that
the SMG1C complex comprised themajority of the purified
protein, as later confirmed by EM. Similar strategies were
performed to purify SMG-1 and SMG-1:SMG-9. However,
the purification of SMG-1 or SMG-1:SMG-9 revealed the
presence of trace amounts of ‘‘contaminant’’ endogenous
SMG-8 bound to exogenously expressed SMG-1:SMG:9,
and endogenous SMG-8 and SMG-9 bound to exogenously
expressed SMG-1 (Supplemental Fig. S3). The SMG-1:SMG-9
complex was successfully purified from cell extracts
expressing SBP-SMG-1 and HA-SMG-9 together with
the cotransfection of siRNA expression plasmid targeting
SMG-8 (Fig. 1D; Supplemental Fig. S3). SMG-1 was puri-
fied from human cells after removing endogenous SMG-8
and SMG-9 using a sequential protocol where contaminant
SMG-8 and SMG-9 were removed by immune depletion
with specific antibodies (Fig. 1E; Supplemental Fig. S3).
3D structure of SMG-1:SMG-9
The SMG-1:SMG-9 complex was the best behaved of all
of our preparations, and it was thus the target of our
primary characterization of SMG-1 complexes. Images
(15,608) of SMG-1:SMG-9 after negative staining were col-
lected, and reference-free two-dimensional (2D) classifica-
tion and averaging of these images revealed an elongated
3D structure of the SMG1C complex
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molecule with rough dimensions of 103 123 16 nm (Fig.
2A; Supplemental Fig. S4). A characteristic view of the
complex showed a shape evocative of a questionmark (Fig.
2A). Several ab initio reconstructions of SMG-1:SMG-9
were performed by the random conical tilt (RCT) method,
where pairs of tilted and untilted images for each molecule
were used to obtain structures of those molecules bound to
the support film in the same orientation (Supplemental Fig.
S5). We then refined the total data set using angular re-
finement methods and several initial templates for re-
finement, including the RCT reconstructions and random
Gaussian blobs to discard a significant bias by the initial 3D
reference (Supplemental Fig. S6). The data set consistently
refined to a 24 A˚ structure of SMG-1:SMG-9 comprising a
voluminous head connected to a thinner extension, the
‘‘arm’’ (Fig. 2C), and, importantly, the projections of the
structure obtained matched the reference-free averages
(Fig. 2A,B). We also performed EM experiments using
unstained specimens preserved at liquid-nitrogen temper-
ature (cryo-EM). Collecting cryo-EM data was complicated
by the size of the complex and the low concentration of the
sample. Cryo-EM images (15,500) of SMG-1:SMG-9 were
collected, and reference-free 2D averages revealed a mole-
cule with a prominent head and a thin arm (Fig. 2D;
Supplemental Fig. S4). The 30 A˚ resolution cryo-EM
structure of SMG-1:SMG-9 agreed well with the stained
reconstructions (Fig. 2E).
Molecular architecture of SMG-1 and the
SMG-1:SMG-9 complex
The structure of SMG-1:SMG-9 was compared with the
structural models of DNA-PKcs, since this is the only
PIKK for which high-resolution structural information is
available (Supplemental Fig. 1; Sibanda et al. 2010). EM and
crystallographic studies have shown that DNA-PKs con-
tains a bulky region (head) containing the catalytic domain
and likely all domains corresponding to the conserved
C-terminal region, and two arms extending outward from
the C-terminal region—one of them proposed to contain
the N-terminal end of the molecule (Rivera-Calzada et al.
2005; Sibanda et al. 2010). These arms comprised regions
of HEAT repeats arranged as superhelical structures. The
limited resolution of those studies prevented a definition
of the arrangement of the polypeptide chain in the struc-
ture, and how the HEAT repeats at the N-terminal side of
the conserved C terminus can organize two arms pro-
jecting from the C-terminal end of the molecule is unclear
(Supplemental Fig. S1). Except for a unique C-terminal
insertion, the primary structure of SMG-1 is similar to
other PIKK members and DNA-PKcs, but the extensive
HEAT repeat region is significantly shorter in SMG-1
(Perry and Kleckner 2003). This similarity allowed the
comparison between SMG-1 and DNA-PKcs, both show-
ing a ‘‘bulky’’ head likely corresponding to the C-terminal
portion of the molecule containing the kinase domain (Fig.
3D; Supplemental Fig. S1). Interestingly, SMG-1:SMG-9
revealed just one arm projecting from the head region,
which would be consistent with the shorter HEAT repeat
region present in the primary structure of SMG-1 com-
pared with DNA-PKcs (Fig. 1A). This superhelical HEAT
repeat region in SMG-1 formed a bent arm, as in DNA-
PKcs (Rivera-Calzada et al. 2005; Sibanda et al. 2010).
Several labeling experiments supported the structural
model of SMG-1 based on the comparison with DNA-
PKcs (Fig. 3). The SMG-1:SMG-9 complex was incubated
with an excess of different antibodies, and the immune
complexes were visualized in the electron microscope
(see the Materials and Methods). Images of SMG-1:SMG-9
incubated with a monoclonal antibody against residues
3547–3657 at the C terminus of SMG-1 consistently re-
vealed an extra density, the putative antibody, which, in
those favorable cases where the view of SMG-1:SMG-9
suggested the location of the head and arm regions, was
found mapping the head region, consistent with the
assignment of the head to the C terminus (Fig. 3A). The
N terminus of SMG-1 wasmapped by labeling the SBP tag
using streptavidin coupled to a gold particle 5 nm in
diameter (Fig. 3B) or an anti-SBP antibody (Fig. 3C). In
Figure 2. 3D-EM structure of SMG-1:SMG-9. (A,B) Reference-
free 2D averages of SMG-1:SMG-9 (A) compared with projections
of the 3D structure (B) obtained after angular refinement.Bar, 10
nm. (C) Two views of the 3D structure of the SMG-1:SMG-9
complex obtained by angular refinement methods. (D) Reference-
free 2D averages obtained from unstained specimens of the
SMG-1:SMG-9 complex. Bar, 10 nm. (E) Cryo-EM structure of
SMG-1:SMG-9.
Arias-Palomo et al.
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both cases, the majority of images obtained revealed the
label in proximity to the narrower end of SMG-1:SMG-9,
compatible with the proposed location of the N terminus
of SMG-1 at the arm region (Fig. 3D).
SMG-9 in SMG-1:SMG-9 was located by difference
mapping between the 3D structures of SMG-1 and SMG-
1:SMG-9. Our preparation of purified SMG-1 was con-
firmed to be free of contamination by SMG-8 and SMG-9
by Western blotting (Fig. 1D; Supplemental Fig. S3).
Unfortunately, the amount and concentration of this
material was very low, and SMG-1 was apparently un-
stable, since images collected in the electron microscope
showed poor quality, and many reference-free averages
appeared blurred and featureless (data not shown). None-
theless, we collected 8032 particles from the best of our
preparations, and distorted particles were removed from
the data set by computationally selecting 3750 images
showing better correlation with projections of SMG-1:
SMG-9 (see the Materials and Methods; Supplemental
Fig. S4F). These images, refined using the structure of
SMG-1:SMG-9 as the initial template for refinement and
parameters in EMAN that reduce model bias (classiter = 8)
(Ludtke et al. 1999), consistently converged to a structure
of SMG-1 at 27 A˚ resolution (Fig. 3E). As a control, an
independent refinement was performed with 11,358 par-
ticles from a SMG-1 sample containing residual traces of
SMG-1:SMG-8:SMG-9 complexes (Supplemental Fig. S3C)
after the images from these contaminants were computa-
tionally eliminated from the data set by removing those
images that showed a high correlation with the structure
of SMG-1:SMG-8:SMG-9 (described below). This indepen-
dent data set generated an identical structure of SMG-1,
supporting the consistency of the differences found be-
tween SMG-1 and SMG-1:SMG-9 (data not shown).
SMG-1 showed an overall similarity with SMG-1:SMG-9,
except that the head region tilts slightly and approaches
the arm region. Interestingly, a significant density was
found to disappear at the level of the arm (Fig. 3E, labeled
with an asterisk in SMG-1:SMG-9). We calculated a differ-
ence map between SMG-1:SMG-9 and SMG-1 after align-
ment of the two structures (Fig. 3F). The head and arm
regions of both molecules were aligned separately to
account for the minor conformational change observed
between the two molecules. Differences were found only
at a precise location, which unequivocally mapped SMG-9
as a density bound to the arm region containing the HEAT
repeats (Fig. 3F, purple). This finding would be consistent
with the biochemical experiments performed (see below).
The volume occupied by SMG-9 in SMG-1:SMG-9 was
roughly consistent with a 40- to 60-kDa globular protein,
Figure 3. 3D architecture of SMG-1 and the SMG-1:SMG-9
complex. (A) Immunolabeling of SMG-1:SMG-9 complexes using
a monoclonal antibody targeting residues 3547–3657 at the C
terminus of SMG-1. (B) Labeling of SMG-1:SMG-9 complexes
using a 5-nm gold particle coupled to streptavidin binding the
SBP tag at the N terminus of SMG-1. (C) Immunolabeling of
SMG-1:SMG-9 complexes using a monoclonal antibody targeting
the SBP tag at the N terminus of SMG-1. The bottom panels of
A–C highlight the position of the protein and the antibody in the
single images by removing the surrounding background. Anti-
bodies targeting the C terminus are colored in green, whereas
those labeling the N terminus are colored in blue. (D) Cartoon
model of SMG-1:SMG-9 with the proposed location for the
N-terminal and C-terminal domains of SMG-1 and SMG-9. (E)
Structure of SMG-1 and its comparison with the structure of
SMG-1:SMG-9. (*) The region of density in SMG-1:SMG-9 that is
not present in SMG-1. (F) Difference map of SMG-1:SMG-9 and
SMG-1 (purple) superimposed on the structure of SMG-1:SMG-9,
shown as a transparency.
3D structure of the SMG1C complex
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based on the number of voxels occupied and the average
density of proteins.
SMG-8 induces large conformational changes
in the SMG1C complex
We analyzed the 3D structure of SMG1C by EM using
similar methodology (Supplemental Figs. S4, S7), and the
2D averages revealed a molecule clearly distinct from
SMG-1:SMG-9 (Fig. 4A). SMG1C showed longitudinal
dimensions similar to SMG-1:SMG-9 and a bulky head,
but the arm region now appeared to be embedded within
a wider molecule. In these images, the outline of a thin
and bent arm containing a region of lower density at its
center was similar to the arm found in the structure of
SMG-1:SMG-9 (Fig. 2), but a dot of density was now
clearly attached (Fig. 4C). SMG-8 was mapped in SMG1C
as this clear density by aligning reference-free averages of
SMG1:SMG-9 and SMG1C and calculation of a difference
image (Fig. 4D, middle panels). Images (13,853) of SMG1C
were processed to obtain a 3D structure of the complex
at a resolution of 24 A˚ (Fig. 4E). The consistency of the
reconstruction was supported by the strong resemblance
between the projections of the structure of the complex
obtained after 3D refinement and 2D reference-free averages
(Fig. 4A,B). Then, SMG-8was located in the 3D structure by
comparing reference-free averages of SMG1C—in which
SMG-8 had beenmapped as the difference image of SMG1C
and SMG-1:SMG-9 (Fig. 4D, middle panels)—with all
possible projections of the structure by cross-correlation.
The best match placed the density of SMG-8 as a precise
density in the 3D structure (Fig. 4D, bottom panels).
SMG1C showed a prominent head region (Fig. 4E, green),
whereas the arm revealed—in addition to the density
mapped above as corresponding to SMG-8 (Fig. 4E,
orange)—a region whose overall shape (roughly triangular
and with lower density in its center) was similar to the
structure of the bent arm in SMG-1:SMG-9, although with
a different orientation (Fig. 4E, purple and blue). Based on
this similarity, SMG-9 (Fig. 4E, purple) and the arm of
SMG-1 (Fig. 4E, blue) could be placed within the structure
of SMG1C, and, interestingly, SMG-8 was found contact-
ing SMG-9. SMG-8 and SMG-9 appeared to form a complex
within SMG1C, a finding that justifies the requirement of
SMG-9 for the recognition between SMG-1 and SMG-8
(Fig. 1B; Yamashita et al. 2009), and previous findings
indicating that SMG-8 and SMG-9 interact in the absence
of SMG-1 (Fernandez et al. 2010). Remarkably, a motion of
the arm of SMG1C when compared with SMG-1:SMG-9
was observed (Fig. 4E, blue), and the 3D structure of the
Figure 4. 3D architecture of the SMG1C
complex. (A,B) Reference-free 2D averages
of SMG1C (A) compared with projections of
the 3D structure of SMG1C (B). Bar, 10 nm.
(C) Cartoon of a 2D average of SMG1C. (D)
Comparison and difference between 2D
reference-free averages of SMG-1:SMG-9
(top left) and SMG-1:SMG-8:SMG-9 (top
right). The difference image (orange) lo-
cates the position of SMG-8 in the SMG1C
complex, and is represented superimposed
on the average of SMG-1:SMG-9 (middle
left) and SMG1C (middle right). Several
2D averages of SMG1C were cross-corre-
lated with projections of the 3D structure
of SMG1C, permitting the assignment of
the mass detected by difference mapping,
SMG-8, within the structure of SMG1C.
All of the different averages used mapped
the same density. (E) Views of the 3D
structure of SMG1C compared with the
compatible view in SMG-1:SMG-9. Color
codes are as follows: The putative map-
ping of SMG-8 is colored in orange, the
C-terminal head region is in green, the
N-terminal arm domain is in blue, and
SMG-9 is in purple.
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C-terminal region of SMG1C showedmanifest differences
from that of SMG-1:SMG-9 (Fig. 4E, green), despite SMG-8
contacting only the N terminus of SMG-1:SMG-9.
The N terminus of SMG-1 recruits SMG-8 and SMG-9
Several experiments were performed to test the structural
model of SMG1C in the presence of RNaseA to remove
RNA-mediated interactions. Initially, several SBP-tagged
constructs of SMG-1 were expressed in 293T cells, and
the presence of bound SMG-8 and SMG-9 was tested after
affinity purification in the presence of RNaseA and West-
ern blotting (Fig. 5A). Consistent with the structural
model, whereas full-length SMG-1 (SMG-11–3657) and an
N-terminal fragment (SMG-11–1977) were capable of bind-
ing both SMG-8 and SMG-9, a C-terminal fragment
containing the kinase domain (SMG-12068–3657) did not
bind detectible amounts of these two proteins (Fig. 5B).
Similar experiments were performed with Flag-tagged
fragments SMG-11–3657, SMG-1153–3657, SMG-1618–365,
SMG-11476–3657, and SMG-12068–3657, which were designed
based on the evolutionally conserved regions at the
N-terminal side of SMG-1 (Fig. 5A; Morita et al. 2007).
These experiments revealed that, whereas SMG-1153–3657
recognized SMG-8 and SMG-9 as efficiently as the full-
length protein, SMG-1618–3657 showed a significant reduc-
tion in the amount of SMG-8 and SMG-9 bound to SMG-1
(Fig. 5C,D). As a whole, these results would be consistent
with a role of the N-terminal side of SMG-1 (Fig. 1A) as the
module implicated in the assembly of SMG-8 and SMG-9.
SMG-8 regulates the kinase activity of SMG-1 on Upf1
We evaluated the role of SMG-8 and SMG-9 in regulating
the kinase activity of SMG-1 in vitro on a GST fusion
peptide containing residue Ser 1096 of Upf1 (GST-Upf1-
S1096), which can be phosphorylated by SMG-1, and this
phosphorylation can be detected using the anti-phospho-
ATM/ATR antibody (Fig. 6; Yamashita et al. 2009). We
tested the activity of the recombinant SMG1C and SMG-
1:SMG-9 complexes purified using methods identical to
those used for the complexes visualized in the electron
microscope. The purity of these preparationswas analyzed
by SDS electrophoresis, and we verified that SMG-8 was
not a contaminant in the SMG-1:SMG-9 sample (Fig. 6A).
SMG-1 was also purified, but these preparations appeared
to be unstable, resulting in nonreproducible measurements
of its kinase activity, in agreement with the behavior of
SMG-1 when analyzed by EM. Thus, the kinase activity of
SMG-1 was not further analyzed. These experiments
revealed that the recruitment of SMG-8 down-regulated
the kinase activity of the SMG-1:SMG-9 complex (Fig.
6B,C). The effect of SMG-8 on the kinase activity of
SMG-1:SMG-9 complexes was further explored by the
purification of recombinant SMG-8 (Supplemental Fig. S8)
and the analysis of the kinase activity of recombinant
SMG-1:SMG-9 in the presence of increasing amounts of
SMG-8. SMG-8 was found to suppress the activity of the
SMG-1:SMG-9 complex in a dose-dependent manner
(Fig. 6D).
To assess the effect of SMG-8 under conditions closer
to those found in vivo, we also purified endogenous
complexes of the SMG-1 kinase by immunopurification,
and its kinase activity was tested using its natural sub-
strate, the Upf1 protein. We immunopurified SMG-1:
SMG-8:SMG-9 and SMG-1:SMG-9 complexes from cell
extracts using anti-SMG-1-C antiserum (Yamashita et al.
2001), and the presence or absence of each subunit in the
complex was verified by Western blotting (Fig. 7A). To
purify SMG-1:SMG-9, SMG-8 was knocked down by
siRNA. The kinase activity of the endogenous SMG-1
complexes on purified recombinant Upf1 (Supplemental
Fig. S9) showed that SMG-8 specifically reduced the
amount of phosphorylation of SMG-1 on Upf1 (Fig. 7B,C).
Discussion
Here, we reveal the 3D architecture of SMG-1 and the
SMG1C complex (Yamashita et al. 2009; Fernandez et al.
2010). SMG-1 is organized in two major structurally
Figure 5. SMG-8 and SMG-9 bind the N-terminal region of
SMG-1. (A) SBP-tagged and Flag-tagged SMG-1 plasmids used.
(B–D) 293T cells were transfected with SBP-tagged (B) and Flag-
tagged (C,D) SMG-1 plasmids shown in A, together with
a plasmid expressing the siRNA targeted to the 39 untranslated
region (UTR) of SMG-1. Cells were lysed and pulled down with
the streptavidin sepharose (B) or anti-Flag (C,D) antibody in the
presence of RNaseA. Pulled-down products or cell lysates (in-
put) were then probed with the antibodies shown on the right.
3D structure of the SMG1C complex
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distinct regions: a head and an arm projecting outward
from the head. SMG-1, as well as all other members of the
PIKK family of kinases, contains a conserved C-terminal
region comprising the kinase domain as well as two
conserved a-helical domains named FAT and FATC,
whereas an extensiveN-terminal domain ismade of poorly
conserved helical regions, mainly HEAT repeats, arranged
as superhelical structures (Fig. 1A; Perry and Kleckner
2003). Atomic information on any PIKK kinase is lacking,
but DNA-PKcs is best characterized by EM and a 6.6 A˚
resolution crystallographic model where the polypeptide
chain was not traced (Rivera-Calzada et al. 2005; Sibanda
et al. 2010). These studies reveled that the kinase, FAT, and
FATC domains of DNA-PKcs are organized as a compact
region (the head), whereas the long N-terminal HEAT
repeat domain, accounting for 70% of the protein, ap-
peared, at least a large part of it, as two twisted helical arms
forming an open ring (Supplemental Fig. S1). In these
studies, the kinase domain was unambiguously mapped
at the top of the head with the catalytic site accessible,
using antibody-labeling experiments and computational
fitting in the EM structures (Rivera-Calzada et al. 2005;
Sibanda et al. 2010) and by direct detection of the PI3K fold
in the crystal structure (Sibanda et al. 2010). How the
HEAT repeat regions at the N terminus of DNA-PKcs can
organize in two arms projecting from the C-terminal head
is uncertain given the lack of higher-resolution structures.
The comparison of the structure of SMG-1 with that of
DNA-PKcs, as well as the antibody-labeling performed in
this study, strongly suggests that the head domain in SMG-1
comprises the catalytic kinase domain and probably
most of the conserved C-terminal domains, including
a C-terminal insertion unique to SMG-1. The function of
this C-terminal insertion is unknown, and this region
Figure 6. Kinase activity of recombinant SMG-1:SMG-9 and
SMG-1:SMG-8:SMG-9 complexes. (A) Fifty femtomoles of
SMG-1 complexes was separated by SDS-PAGE and silver-
stained. (B) In vitro kinase assay using 10 fmol of purified
complexes and 30 pmol of GST-Upf1-S1096 peptide as the
substrate. (C) Quantification of the phosphorylation level of
GST-Upf1-S1096 in vitro. Relative values against the 5-min
activity of the SMG-1:SMG-8:SMG-9 complex are shown. Mean
values6 SD from three independent experiments are shown. (D)
In vitro kinase assay using the indicated amount of purified
SMG-8, 10 fmol of purified SMG-1:SMG-9 complex, and 30
pmol of GST-Upf1-S1096 peptide as a substrate for 10 min.
Figure 7. Kinase activity of endogenous SMG-1:SMG-9 and
SMG-1:SMG-8:SMG-9 complexes. (A) HeLa TetOff cells were
transfected with the nonsilencing siRNA (for those experiments
labeled as ‘‘no kinase’’ and ‘‘SMG-1:SMG-8:SMG-9 complex’’) or
siRNA targeted to SMG-8 (for the SMG-1:SMG-9 complex).
SMG-1 complexes were immunoprecipitated with preimmune
serum (labeled ‘‘no kinase,’’ since it should not immunoprecip-
itate SMG-1) or anti-SMG-1-C antiserum for the SMG-1:SMG-
8:SMG-9 complex and the SMG-1:SMG-9 complex, and were
analyzed by Western blotting. (B) In vitro kinase assay with
SMG-1 immunoprecipitates using and SBP-Upf1 as a substrate.
(C) Quantification of the phosphorylation level of SBP-Upf1 in
vitro. Relative values against a nonsilencing siRNA-treated
control are shown. Mean values from two independent experi-
ments are shown.
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is missing in the SMG-1 ortholog in Caenorhabditis
elegans, suggesting that it might be an adaptation to a
more complex regulation acquired during evolution. Bio-
chemical mapping has implicated a C-terminal fragment
of SMG-1 containing the kinase domain, this insertion,
and the FATC domain in recognition of Upf2 (Kashima
et al. 2006). Since the interaction between SMG-1 and the
Upf1:Upf2:Upf3 complex regulates the activation of
SMG-1 and Upf1 phosphorylation, a tight structural as-
sociation among the C-terminal domains in SMG-1 could
facilitate complex regulatory interplays. For instance,
interactions of the C-terminal FATC and the unique
insertion with other proteins (Upf2, for instance) could
contribute to regulation by inducing conformational
changes in the kinase domain nearby. The kinase domain
in the PIKK family is homologous to PI3Ks; thus, these
mechanisms could be similar to the regulation described
for PI3K, where a helical domain tightly packs with the
catalytic domain, and interactions of regulatory subunits
with this helical domain suppress the kinase activity
(Lempiainen and Halazonetis 2009).
The region of SMG-1 defined as the arm would com-
prise the HEAT repeats placed N-terminal to the con-
served head. This arm domain is bent, similar to what it is
found in DNA-PKcs (Supplemental Fig. S1) and other
HEAT repeat-containing proteins. Interestingly, SMG-1 is
composed of one rather than the two arm regions found in
DNA-PKcs. Approximately 70% of the residues in DNA-
PKcs primary structure (;2800 amino acids out of 4127)
correspond to the helical repeats placedN-terminal to the
conserved FAT, kinase, and FATC domains, suggesting
that this longer HEATrepeat region is accommodated as a
duplication of the arm rather than a longer single-helical
structure.
We found that the N-terminal region of SMG-1 func-
tions as a scaffold for SMG-9. The results obtained in the
interaction assays, combined with the structure of the
SMG-1:SMG-9 complex and its comparison with DNA-
PKcs, indicate that the HEAT repeats of SMG-1 recognize
SMG-9. This finding agrees with the general role of HEAT
repeats as protein scaffolds. The interaction of SMG-1 and
SMG-9 enhances the stability of SMG-1, which, in our
hands, damages frequently during purification and/or
storage. SMG-8 interacts with SMG-9 when it is a part
of SMG1C, and the evidence supports that SMG-9 re-
cruits SMG-8 to the complex: (1) SMG-8 and SMG-9 form
complexes in solution devoid of SMG-1 (Fernandez et al.
2010), and this interaction would likely be maintained
when bound to SMG-1. (2) The C-terminal domain of
SMG-9 binds SMG-8 (Fernandez et al. 2010). (3) Whereas
SMG-1 and SMG-9 interact to form the SMG-1:SMG-9
complex, SMG-8 complexes with SMG-1 mostly contain
SMG-9 (Fig. 1B). (4) Both proteins interact in vivo with the
same region of SMG-1 (Fig. 5). Thus, we propose that
SMG-9 possibly functions as a bridge between SMG-1 and
SMG-8. Given the central role of SMG-9 in the assembly
of SMG1C, it is possible that the modulation of SMG-1
might be controlled via a regulated assembly pathway of
SMG1C directed by SMG-9. Although SMG-9 has been
found capable of forming SMG-9:SMG-9 homodimers
(Fernandez et al. 2010), the region occupied by SMG-9
in the structure of the SMG-1:SMG-9 complex is more
compatible with a monomer of SMG-9 bound to SMG-1,
and it could hardly accommodate a 120-kDa dimer.
Regions composed of adjacent HEAT repeats are pres-
ent in many proteins acting as scaffolds for protein–
protein interactions, usually adopting a superhelical
structure. These structures are prone to conformational
changes induced by the interaction with a partner, as
revealed by the structure of importin 13 bound to Mago-
Y14 (Bono et al. 2010). In the SMG1Ccomplex, an apparent
motion of the HEAT repeat-containing arm region is
detected after SMG-8 binding to SMG-1:SMG-9. Impor-
tantly, whereas biochemical and structural data show that
SMG-8 contacts SMG-1 far away from the location of the
kinase domain, inferred from its location in DNA-PKcs
(Supplemental Fig. S1), SMG-8 is found to strongly down-
regulate the catalytic activity of SMG-1 (Figs. 6, 7). This
modulation correlates with the conformational changes
we observed in the C-terminal head domain in SMG1C
containing the catalytic domain (Fig. 4), thus suggesting
that conformational changes in the N-terminal region
would be transmitted to the head. Consistent with this
idea, the N-terminal region of SMG-1 has been found to be
essential for its kinase activity (Morita et al. 2007).
In conclusion, SMG-8-induced conformational changes
modulate SMG-1 activation, and SMG-9 seems to be
a major controller of SMG1C assembly by recruiting
SMG-8 to SMG-1 (Fig. 8). SMG-9 could bind SMG-1 first
to recruit SMG-8, or, alternatively, SMG-8 could be
recruited as part of a preassembled SMG-8:SMG-9 com-
plex, since SMG-8:SMG-9 complexes that do not contain
SMG-1 have been detected previously (Fernandez et al.
2010). Then, SMG-8 recruits the inactive SMG1C com-
plex to the PTC recognition complex (Yamashita et al.
2009). The N-terminal and C-terminal domains of SMG-9
are essential for binding to SMG-1, whereas only the
C terminus of SMG-9 is required to recruit SMG-8 to the
complex (Fernandez et al. 2010). SMG-8 and SMG-9 bind
to the HEAT repeat region of SMG-1, inducing large-scale
conformational changes that modify the conformation of
the catalytic domain, and tuning the kinase activity of
SMG-1 to the requirements of NMD machinery.
Figure 8. Model of the regulation of the kinase activity of
SMG-1 through the assembly of the SMG1C complex. SMG-8
could be recruited to a preformed SMG-1:SMG-9 complex or as
part of a pre-existing SMG-8:SMG-9 complex.
3D structure of the SMG1C complex
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Materials and methods
Plasmids
pEF_Flag-HA-SBP-SMG-1 (1–3657), pEF_Flag-HA-SBP-SMG-1
(126–3657), pSR_Strep-HA-SMG-9 (2–520), pSR_HA-SMG-8
(2–991), and pEF_Flag-HA-SBP-SMG-8 (2–991) plasmids were
constructed by cloning each cDNA fragment using standard meth-
ods. siLentGene-puro-siSMG8cds, siLentGene-puro-siSMG9cds, or
siLentGene-puro-siSMG1cds, U6 promoter-driven shRNA expres-
sion vectors (siLentGene-puro; Promega) used for SMG-8 (siRNA
sequence: siGENOME duplex D-016480-02 [Dharmacon]), SMG-9
(siRNA sequence: siGENOME duplexD-020561-01 [Dharmacon]),
or SMG-1 (siRNA sequence: GTGTATGTGCGCCAAAGTA), re-
spectively, were constructed as described in the manual.
pNTAP-SMG-1-N (amino acids–1977), pNTAP-SMG-1-C
(amino acids 2068–3657), pSR_Flag-SMG-1 full (1–3657),
pSR_Flag-SMG-1153–3657, pSR_Flag-SMG-1618–3657, pSR_Flag-
SMG-11476–3657, pSR_Flag-SMG-12068–3657, and siLentGene-puro-
siSMG-1UTR (siRNA sequence targeted to the 39 untranslated
region [UTR] of the SMG-1 mRNA; target sequence: GGAA
GATTTGATGCATTCA) were described previously (Morita
et al. 2007; Izumi et al. 2010).
Antibodies
SMG-1 and SMG-8 antibodies used in immunodepletion exper-
iments were generated against recombinant human SMG-1
(amino acids 1827–1925) or human SMG-8 (amino acids 621–
734) proteins fused to maltose-binding protein (MBP). Affinity
purification of antibodies was performed using standard proce-
dures. Anti-SMG-1, anti-SMG-8, and anti-SMG-9 antibodies used
in Western blotting have been described previously (Yamashita
et al. 2009). Anti-HA-HRP (clone 3F10) (Roche), anti-Flag (clone
M2) (Sigma), anti-mTOR (Cell Signaling Technology), and
anti-aPKCl (C-20) (SantaCruz Biotechnology) were obtained
commercially.
Purification of SMG-1, SMG-1:SMG-9, SMG-1:SMG-8:SMG-9,
SMG-8, and Upf1
For the SMG1C (SMG-1:SMG-8:SMG-9) complex, 5 3 108 293T
cells were cotransfected with pEF_Flag-HA-SBP-SMG-1 (1–3657),
pSR_Strep-HA-SMG-8 (2–991), and pSR_Strep-HA-SMG-9 (2–520)
plasmids at a 2:1:1 ratio using HEKfectin (Bio-Rad). For the SMG-
1:SMG-9 complex, 5 3 108 293T cells were cotransfected with
pEF_Flag-HA-SBP-SMG-1 (126–3657), pSR_Strep-HA-SMG-9
(2–520), and siLentGene-puro-siSMG-8cds at a 2:1:1 ratio using
HEKfectin (Bio-Rad). For SMG-1, 5 3 108 293T cells were
cotransfected with pEF_Flag-HA-SBP-SMG-1 (126–3657), siLent-
Gene-puro-siSMG-9cds, and siLentGene-puro-siSMG-8cds at a
2:1:1 ratio using HEKfectin (Bio-Rad). For SMG-8, 1 3 108 293T
cells were cotransfected with pEF_Flag-HA-SBP-SMG-8 (2–991),
siLentGene-puro-siSMG-9cds, and siLentGene-puro-siSMG-
1cds at a 1:1:1 ratio using HEKfectin (Bio-Rad). For Upf1, 1 3
108 293T cells were transfected with pSR_myc-SBP-Upf1. Two
days after transfection, cells were lysed with a loose-fit Potter-
Elvehjem homogenizer in F-buffer (10 mM HEPES-KOH at pH
7.5, 50 mM NaCl, 10% [w/v] glycerol, 10 mM MnCl2, 50 mM
b-glycerophosphate, 1 mM DTT, protease inhibitor cocktail
[Roche], phosphatise inhibitor cocktail [Roche]) with 100 mg/
mL RNaseA. The soluble fractions were precleared with
sepharose 4B (Sigma) and then incubated with streptavidin
sepharose (GE Biotech) for 2 h at 4°C with gentle rotation. After
washing with RNase() F-lysis buffer, the affinity-purified pro-
tein complexes were eluted by incubation for 30 min at 4°C
with RNase() lysis buffer containing 2 mM biotin (Sigma).
For the purification of SMG-1, the fractions containing SMG-1
were incubated with 4 mg of anti-SMG-8 and 2 mg of anti-
SMG-9 antibodies for 1 h at 4°C, then incubated with Protein-
G-Dynabeads for 1 h at 4°C to immunodeplete SMG-8 and
SMG-9. The supernatant collected contained purified SMG-1.
Negatively stained EM and 3D reconstructions
SMG-1, the SMG-1:SMG-9 complex, and SMG1C were observed
in a JEOL JEM-1230 electron microscope operated at 100 kV after
stainingwith 2%uranyl formate. Images of singlemoleculeswere
extracted from micrographs recorded at a nominal magnification
of 50,0003 under low-dose conditions and were scanned at a final
4.2 A˚ per pixel. Micrographswere taken at 0° and 20° tilting of the
specimen holder to increase the number of views of the mole-
cules.More than 20,000 images for each of the complexes—SMG-
1:SMG-9 and SMG-1:SMG-8:SMG-9—were initially extracted.
Reference-free 2D methods implemented in EMAN (Ludtke
et al. 1999) and 2D maximum-likelihood classification (Scheres
et al. 2005) implemented in XMIPP (Scheres et al. 2008) were
used to analyze the data from each of these samples. 2D
classification was used to remove distorted particles from the
data set to end up with 15,608 images of SMG-1:SMG-9 and
13,853 images of SMG-1:SMG-8:SMG-9 for subsequent analysis.
3D structures of SMG-1:SMG-9 and SMG-1:SMG-8:SMG-9 were
obtained by angular refinement methods (Supplemental Fig. S4)
using several starting templates, which converged to similar
structures, supporting the consistency of the final structures
(Supplemental Figs. S6, S7). Among these references, we used
several unbiased Gaussian blobs of different shapes generated
with EMAN. In addition, we performed an ab initio reconstruc-
tion of SMG-1:SMG-9 using the RCTmethod, with images of the
same field taken at 0° and 50° tilting and using XMIPP (Supple-
mental Fig. S5; Scheres et al. 2008). Angular refinement was
performed by projection matching combined with a maximum-
likelihood algorithm using XMIPP (Scheres et al. 2008). The
handedness of the reconstructions defined by the RCT models
was the one that best matched the atomic model of DNA-PKcs,
and this was used for rendering. The resolution of the reconstruc-
tions was estimated to correspond to 24 A˚ for SMG-1:SMG-9 and
24 A˚ for the SMG1C complex, using a cutoff of 0.5 of the Fourier
shell correlation coefficient (Supplemental Fig. S4). Importantly,
the consistency of the final structures of SMG-1:SMG-9 and
SMG-1:SMG-8:SMG-9 was supported by the agreement between
2D averages obtained by reference-free methods and the 2D
averages and projections after angular refinement (Figs. 2, 4).
Particles (8032) of purified SMG-1 (Fig. 1E) were collected.
SMG-1 seemed prone to distortions, and reference-free 2D aver-
ages revealed particles of different quality. The best images of
SMG-1 were selected computationally as those with the best
cross-correlation with projections of the 3D structure of SMG-1:
SMG-9. These images were extracted, which showed overall
features similar to those of SMG-1:SMG-9 after reference-free
averaging. The data set was refined using the structure of SMG-1:
SMG-9 as a template and using parameters in EMAN to reduce
model bias (classiter = 8) (Ludtke et al. 1999). From the first step of
refinement, the resulting structure revealed differences from the
template, which were further refined until convergence. During
refinement, those class averages visually judged to be of poor
quality were not used to build the new model. The final structure
at a resolution of 27 A˚ was reconstructed using 3750 images.
Images (11,358) of a different data set obtained from the sample
shown in Supplemental Fig. S3were also analyzed. Contamination
by images of SMG1C complexes was computationally removed by
supervised classification of the data set using as templates the
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structures of SMG-1:SMG-9 and SMG1C complexes. Particles
correlating better with the structure of SMG-1:SMG-9 were split
and processed independently, and a result similar to that obtained
for the pure SMG-1 sample (Fig. 1E) was obtained.
Antibody labeling of SMG-1:SMG-9
The SMG-1:SMG-9 complex was incubated with a threefold
molar excess of each antibody for 1 h at 25°C, and the immune
complexes were observed in a JEOL 1230 microscope at a nom-
inal magnification of 25,0003 (36,2503 at the camera) using
a TemCam-F416 camera (TVIPS). The following antibodies were
used:monoclonal antibody (M02), clone 1A8 against residues 3547–
3657 of SMG-1 (Abnova), monoclonal antibody against the SBP tag
(SantaCruz Biotechnology). Also, 5-nm gold particles coupled to
streptavidin were used to label the SBP tag (BBInternational).
Cryo-EM and 3D reconstruction of SMG-1:SMG-9
The SMG-1:SMG-9 complex was vitrified using a FEI Vitrobot
after deposition of the sample on Quantifoil R 1.2/1.3 grids
(http://www.quantifoil.com). These grids were decorated pre-
viously with a thin layer of carbon on top to facilitate interaction
of the sample, given the low concentration of the material
purified. Cryo-EM images were recorded on film under low-dose
conditions using a JEM-2200FS electron microscope (JEOL)
operated at 200 kV and equipped with an energy filter to increase
the signal to noise ratio of the images (Supplemental Fig. S4).
Micrographs were scanned to 2.1 A˚ per pixel and averaged to 4.2
A˚ per pixel, and the 15,500 images were extracted using XMIPP
(Scheres et al. 2008). Reference-free 2D averages were obtained
by multivariate statistical analysis using SPIDER (Shaikh et al.
2008). The 3D structure of SMG-1:SMG-9 was refined using
a combination of projection matching and maximum likelihood
as implemented in XMIPP (Scheres et al. 2008), and using the 3D
reconstruction of the complex obtained from stained specimens
after low-pass filtering to lower resolution as the initial tem-
plate. The cryo-EM structure of SMG-1:SMG-9 was solved at a
resolution of 30 A˚ (cutoff of 0.5 of the Fourier shell correlation
coefficient) (Supplemental Fig. S4).
Kinase activity of SMG-1
For those experiments using purified recombinant complexes,
incubations were performed using 10 fmol of purified proteins in
20 mL of 13 kinase reaction mixture (10 mM Hepes-KOH at pH
7.5, 50 mM NaCl, 10% [w/v] glycerol, 10 mM MnCl2, 50 mM
b-glycerophosphate, 1 mM DTT, 0.1%BSA [w/v], phosphatase
inhibitor cocktail [Roche], protease inhibitor cocktail [Roche])
containing 50 mMATP for 5 or 15 min at 30°C (Fig. 6B) or 10 min
at 30°C (Fig. 6D), using 1 mg of purified GST-Upf1-S1096 as
a substrate (Yamashita et al. 2009). After separation by SDS-
PAGE, phosphorylated GST-Upf1-S1096 peptides, amino acids
1090–1113 (QIDVALSQDSTYQG) of Upf1 fused with GST, were
detected by Western blotting using the anti-phospho-ATM/ATR
substrate antibody (Cell Signaling Technology). Signals were
quantified with LuminoImager LAS-3000 and Science Lab 2001
Image Gauge software (Fuji Photo Film).
For those experiments performed using endogenous SMG-1
complexes, cells were lysed in F-buffer. Endogenous SMG-1 was
immunoprecipitated using anti-SMG-1-C antiserum (Yamashita
et al. 2001). Immunoprecipitates were washed with F-buffer
containing 0.25 M LiCl and 13 kinase reaction buffer. Kinase
reactions were carried out in 50 mL of 13 kinase reaction buffer
containing 50 mMATP and 5 mCi [g-32P]ATP for 5, 15, or 30 min
at 30°C using 1 mg of purified wild-type SBP-Upf1 as substrate.
After separation by SDS-PAGE, gels were silver-stained. Then,
phospho-proteins were visualized by autoradiography. The ex-
tent of phosphorylation was evaluated using an imaging analyzer
(BAS2500, Fuji Film).
Interactions assays
293T cells were transfected using HEKfectin (Bio-Rad) and were
lysed with a loose-fit Potter-Elvehjem homogenizer in F-buffer
(10 mM HEPES-KOH at pH 7.5, 50 mM NaCl, 10% [w/v]
glycerol, 10 mM MnCl2, 50 mM b-glycerophosphate, 1 mM
DTT, protease inhibitor cocktail [Roche], phosphatase inhibitor
cocktail [Roche]) with 100 mg/mL RNaseA. The soluble fractions
were precleared with sepharose 4B (Sigma) and then incubated
with streptavidin sepharose (GE Biotech) for 2 h at 4°Cwith gen-
tle rotation. Precleared lysates were incubated with streptavidin-
sepharose or anti-Flag (M2) antibodies for 2 or 1 h at 4°C with
gentle rotation. When using antibodies, the soluble fractions were
subsequently incubated with 30 mL of protein G sepharose (GE
Biotech) for an additional 1 h at 4°C with gentle rotation. After
washing with RNase() F-lysis buffer, the affinity-purified protein
complexes were eluted by incubation for 30 min at 4°C with
RNase() lysis buffer containing 2 mM biotin (Sigma) or 33 Flag
peptide (Sigma), respectively. All proteins in Western blot exper-
iments were detected with an ECLWestern blot detection kit (GE
Biotechnology) or Lumi-Light (Roche). All experiments were
performed two to three times, and typical results are shown.
For immunodepletion analysis, 43 105 HeLa TetOff cells were
lysed with a loose-fit Potter-Elvehjem homogenizer in T-buffer
(20 mMHepes-NaOH at pH 7.5, 50 mMNaCl, 0.05% Tween 20,
2.5 mM MgCl2, 0.5 mM DTT, protease inhibitor cocktail
[Roche], phosphatase inhibitor cocktail [Roche], 100 mg/mL
RNaseA [Qiagen]). The lysates were incubated with 4 mg of the
anti-SMG-1, anti-SMG-8, or anti-SMG-9 antibodies for 1 h at 4°C
with gentle rotation. Subsequently, the soluble fractions were
incubated with 1 mg of protein-G-Dynabease (Veritas) for an
additional 1 h at 4°C with gentle rotation. Antibody–protein
G-Dynabease complexes were removed by magnet and superna-
tants were stored as the ‘‘immunodepleted’’ fraction.
The 3D-EM structures of SMG-1:SMG-9 and SMG1C have
been deposited in the Electron Microscopy Data Bank (EMDB).
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